Marinus Pharmaceuticals Stock Forecast

Stock Price Forecast

The 7 analysts that cover Marinus Pharmaceuticals stock have a consensus rating of "Sell" and an average price target of $5.90, which forecasts a -36.90% decrease in the stock price over the next year. The lowest target is $2.50 and the highest is $11.

Price Target: $5.90 (-36.90%)

Analyst Consensus: Sell

Target	Low	Average	Median	High
Price	$2.50	$5.90	$6.00	$11
Change	-73.26%	-36.90%	-35.83%	+17.65%

Analyst Ratings

The average analyst rating for Marinus Pharmaceuticals stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	0	0	0	0	0	0
Buy	1	1	1	1	1	1
Hold	4	4	4	4	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	2	2	2	2	2
Total	5	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ben Kallo Baird	Baird	Hold Maintains $6 → $11	Hold	Maintains	$6 → $11	+17.65%	Jul 24, 2025
Mark Delaney Goldman Sachs	Goldman Sachs	Strong Sell Maintains $3 → $2.5	Strong Sell	Maintains	$3 → $2.5	-73.26%	Apr 28, 2025
Ben Kallo Baird	Baird	Hold Maintains $8 → $6	Hold	Maintains	$8 → $6	-35.83%	Apr 24, 2025
Mark Delaney Goldman Sachs	Goldman Sachs	Strong Sell Maintains $4 → $3	Strong Sell	Maintains	$4 → $3	-67.91%	Apr 10, 2025
Joseph Spak UBS	UBS	Hold → Strong Sell Downgrades $5 → $2.5	Hold → Strong Sell	Downgrades	$5 → $2.5	-73.26%	Apr 10, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

4.90M

EPS This Year

-0.85

from -0.94

EPS Next Year

-0.76

from -0.85

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	4.90M	79.08M
Revenue Growth	-	-	-	-	-	-	-	1,512.85%
EPS	-6.67	-0.52	-0.95	-0.96	-0.94	-0.85	-0.76	-0.41
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	13	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	10.5M	135.0M
Avg	n/a	4.9M	79.1M
Low	n/a	n/a	33.3M

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	2,654.0%
Avg	-	-	1,512.8%
Low	-	-	579.6%

EPS Forecast

EPS	2025	2026	2027
High	-0.76	-0.63	0.91
Avg	-0.85	-0.76	-0.41
Low	-0.90	-0.84	-0.70

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.